Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.
David M. Paton
págs. 89-102
New frontiers in oncology: Immune checkpoint inhibitors in combination therapy.
Gaetano Romano, A. Gawlinski
págs. 103-116
The year's new drugs & biologics 2016: Part II – Trends and highlights of an unforgettable year.
Ann I. Graul, Coia Dulsat, M. Tracy, Elisabet Cruces
págs. 117-158
New product intros (fimasartan/rosuvastatin calcium [new combination], saxagliptin/dapagliflozin [new combination]).
pág. 159
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: